Research Topics
| Nalini S BoraSummaryAffiliation: University of Louisville Country: USA Publications
| Collaborators
|
Detail Information
Publications
Type I collagen is the autoantigen in experimental autoimmune anterior uveitisNalini S Bora
Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, University of Louisville, Louisville, KY 40202, USA
J Immunol 172:7086-94. 2004..Although human anterior uveitis has been historically characterized as a collagen disease, this is first time collagen has been directly identified as the target autoantigen in uveitis...
Role of complement and complement membrane attack complex in laser-induced choroidal neovascularizationPuran S Bora
Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, University of Louisville, 301E Muhammad Ali Boulevard, Louisville, KY 40202, USA
J Immunol 174:491-7. 2005..It is possible that a similar mechanism may be involved in the pathophysiology of other angiogenesis essential diseases...
Alcohol linked to enhanced angiogenesis in rat model of choroidal neovascularizationPuran S Bora
Department of Ophthalmology and Visual Science, Kentucky Lions Eye Center, University of Louisville, KY, USA
FEBS J 273:1403-14. 2006..These results may provide insight into the link between heavy alcohol consumption and exudative AMD...
Anti-inflammatory effects of specific cyclooxygenase 2,5-lipoxygenase, and inducible nitric oxide synthase inhibitors on experimental autoimmune anterior uveitis (EAAU)Nalini S Bora
Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, School of Medicine, University of Louisville, 40202, USA
Ocul Immunol Inflamm 13:183-9. 2005..Therefore, inhibition of these enzymes may abrogate intraocular inflammation in experimental autoimmune anterior uveitis (EAAU)...
Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degenerationPuran S Bora
Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, KY 40202, USA
Proc Natl Acad Sci U S A 100:2679-84. 2003..Because the Icon binds selectively to the CNV in exudative AMD as well as to laser-induced CNV, the Icon might also be efficacious for treating patients with exudative AMD...
Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cellsJeong Hyeon Sohn
Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, University of Louisville, Louisville, Kentucky, USA
Nat Med 9:206-12. 2003..These observations may extend to the development of both neonatal tolerance and other forms of acquired tolerance...
Novel role for a complement regulatory protein (CD46) in retinal pigment epithelial adhesionBarbara J McLaughlin
Department of Ophthalmology and Visual Sciences, University of Louisville School of Medicine, Louisville, Kentucky, USA
Invest Ophthalmol Vis Sci 44:3669-74. 2003..In this study, a novel role in the retina for a regulatory protein in the complement system, CD46, is proposed...
Molecular characterization of human eye and heart fatty acid ethyl ester synthase/carboxylesterase by site-directed mutagenesisPuran S Bora
Department of Internal Medicine, Division of Cardiology and Geriatric Medicine, Saint Louis University Medical Center, St Louis, MO 63110, USA
Biochem Biophys Res Commun 312:1094-8. 2003....
Pathogenesis of age-related macular degenerationTongalp H Tezel
Department of Ophthalmology and Visual Sciences, Kentucky Lions Eye Center, University of Louisville, Louisville, KY 40202, USA
Trends Mol Med 10:417-20. 2004
Crucial role of apoptosis in the resolution of experimental autoimmune anterior uveitisPurushottam Jha
Department of Ophthalmology, Jones Eye Institute, Little Rock, AR 72205, USA
Invest Ophthalmol Vis Sci 48:5091-100. 2007..Experimental autoimmune anterior uveitis (EAAU) serves as an animal model of human idiopathic anterior uveitis. This study was undertaken to investigate the role of apoptosis in the resolution of EAAU...
Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectinPuran S Bora
Department of Ophthalmology, Jones Eye Institute, Pat and Willard Walker Eye Research Center, 4301 West Markham, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
FEBS Lett 581:1977-82. 2007..Thus, APN inhibited choroidal angiogenesis and may have therapeutic implications in the treatment of wet age related macular degeneration...
Intraocular diseases - anterior uveitisNalini S Bora
Department of Ophthalmology, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205 7199, USA
Chem Immunol Allergy 92:213-20. 2007..Recently, type I collagen was identified as the target autoantigen in EAAU. Thus, human AU may be an e xample of autoimmunity to local ocular collagen...
CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degenerationNalini S Bora
Department of Ophthalmology, Jones Eye Institute, Pat and Willard Walker Eye Research Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
J Immunol 178:1783-90. 2007..Thus, our results suggest that the inhibition of complement by soluble CD59 may provide a novel therapeutic alternative to current treatment...
Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: role of factor B and factor HNalini S Bora
Department of Ophthalmology, Jones Eye Institute, Pat and Willard Walker Eye Research Center, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
J Immunol 177:1872-8. 2006..Thus, specific blockade of the alternative pathway may represent a therapeutically relevant strategy for the inhibition of CNV...
Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU)Purushottam Jha
Department of Ophthalmology, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, 72205, USA
J Immunol 176:7221-31. 2006....
The complement system plays a critical role in the development of experimental autoimmune anterior uveitisPurushottam Jha
Department of Ophthalmology, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA
Invest Ophthalmol Vis Sci 47:1030-8. 2006..The role of complement in ocular autoimmunity was explored in a experimental autoimmune anterior uveitis (EAAU) animal model...
Tolerance to melanin-associated antigen in autoimmune uveitis is mediated by CD4+CD25+ T-regulatory cellsBharati Matta
Department of Ophthalmology, Jones Eye Institute, Little Rock, AR 72205, USA
Am J Pathol 173:1440-54. 2008..In conclusion, T-cell nonresponsiveness because of active suppression mediated by T-regulatory cells facilitates the development of tolerance to MAA in EAAU...
Complement system and the eyePurushottam Jha
Department of Ophthalmology, Jones Eye Institute, 4301 West Markham, 523, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
Adv Exp Med Biol 586:53-62. 2006
Complement, innate immunity and ocular diseaseJeong Hyeon Sohn
Department of Ophthalmology, Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205 7199, USA
Chem Immunol Allergy 92:105-14. 2007....
The role of complement system in ocular diseases including uveitis and macular degenerationPurushottam Jha
Department of Ophthalmology, Jones Eye Institute, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA
Mol Immunol 44:3901-8. 2007..Currently, several clinical trials using complement inhibitors are going on. It is possible that, in the near future, complement inhibitors might be used as therapeutic agents in eye clinics...
The role of complement in ocular pathologyNalini S Bora
Department of Ophthalmology, Jones Eye Institute, University of Arkansas for Medical Sciences, 4301 West Markham, Mail Slot 523, Little Rock, AR 72205, USA
Semin Immunopathol 30:85-95. 2008..It is hoped that in the future recombinant complement regulatory proteins will be used as novel therapeutic agents in the clinic for the treatment of keratitis, uveitis, and age-related macular degeneration...
